Longeveron Inc. July 10, 2024 - by Joey Ramson $LGVN is surging today and leading the Prism MarketView Public Health index today. The FDA has granted Regenerative Medicine Advanced Therapy designation to the company’s Lomecel-B treatment. Share this article:
